Navin Fluorine International Share Price

NSE
NAVINFLUOR •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Navin Fluorine International Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Jun 04, 2024
9
TTM PE Ratio
High in industry
68.6
Price to Book Ratio
High in industry
7.4
Dividend yield 1yr %
Below industry Median
0.3
TTM PEG Ratio
PEG TTM is negative
-2.3

Navin Fluorine International Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Navin Fluorine International Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
518.56 Cr
523.68 Cr
601.95 Cr
501.82 Cr
471.79 Cr

Navin Fluorine International Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
2120.86 Cr
2113.13 Cr
1492.58 Cr
1258.44 Cr
1094.88 Cr

Navin Fluorine International Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
58.82 Cr
51.2 Cr
70.38 Cr
78.02 Cr
60.58 Cr

Navin Fluorine International Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
270.51 Cr
375.19 Cr
263.08 Cr
247.06 Cr
401.37 Cr

Navin Fluorine International Ltd shareholding Pattern

Promoter
28.4%
Foreign Institutions
18.2%
Mutual Funds
15.2%
Domestic Institutions
28.2%
Public
25.2%
Promoter
28.8%
Foreign Institutions
18%
Mutual Funds
13.7%
Domestic Institutions
27.4%
Public
25.8%
Promoter
28.8%
Foreign Institutions
15.6%
Mutual Funds
15.6%
Domestic Institutions
28.6%
Public
27%
Promoter
28.8%
Foreign Institutions
15.9%
Mutual Funds
19.5%
Domestic Institutions
28.9%
Public
26.3%
Promoter
28.8%
Foreign Institutions
19.2%
Mutual Funds
19.8%
Domestic Institutions
26%
Public
26%
Promoter
28.8%
Foreign Institutions
18.5%
Mutual Funds
20.4%
Domestic Institutions
26%
Public
26.7%

Navin Fluorine International Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
3
5Day EMA
3,582.90
10Day EMA
3,559.20
12Day EMA
3,548.00
20Day EMA
3,509.60
26Day EMA
3,488.70
50Day EMA
3,445.40
100Day EMA
3,424.70
200Day EMA
3,464.70
5Day SMA
3,580.70
10Day SMA
3,577.10
20Day SMA
3,469.30
30Day SMA
3,448.90
50Day SMA
3,418.10
100Day SMA
3,408.10
150Day SMA
3,431.80
200Day SMA
3,365.10
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
14145 Rs
57019 Rs
Week Rs
43609 Rs
116323 Rs
Month Rs
42775 Rs
103148 Rs
Resistance & Support
3,584.52
Pivot
Resistance
First Resistance
3,615.03
Second Resistance
3,655.92
Third Resistance
3,686.43
Support
First Support
3,543.63
Second support
3,513.12
Third Support
3,472.23
Relative Strength Index
57.06
Money Flow Index
83.89
MACD
59.27
MACD Signal
50.26
Average True Range
99
Average Directional Index
17.09
Rate of Change (21)
3.26
Rate of Change (125)
1.71

Navin Fluorine International Ltd Company background

Founded in: 1998
Managing director: Nitin G. Kulkarni
Navin Fluorine International Limited was incorporated in June 25th, 1998. Being a flagship, the Company belongs to a reputed industrial house of Padmanabh Mafatlal Group in India. It has largest integrated fluorochemicals complex in India, since 1967. The Company primarily focuses on fluorine chemistry producing refrigeration gases, chemicals, inorganic bulk fluorides, specialty organofluorines and offers Contract Research and manufacturing services. Its 2 manufacturing units at Surat in Gujarat and Dewas in Madhya Pradesh and 1 manufacturing site of Navin Fluorine Advanced Sciences Limited at Dahej in Gujarat are strategically located near ports to facilitate the import of raw materials and the export of finished products. The Companys manufacturing unit was located in Surat. It commenced the refrigerant business in 1967 and established itself as a respected refrigerant global brand. It commissioned Dewas unit in 1978.Navin initiated the CDM project to reduce green house gas HCFC 23 in June 2006 with Ineos Fluor as technology partners and received UNFCCC approval in March 2007. Navin Fluorine has developed more than 40 products on commercial scale using indigenously built multipurpose plants.The company has ability to produce some of the niche organofluorine molecules. It offers a diversified portfolio of advanced fluorine derivatives to the world with wide ranging applications in pharma, agro and petrochemicals. Navin Fluorine has an impressive clientele consisting of several fortune 500 companies, which include five of the top ten global crop protection companies and three of the top ten global chemical companies.A positive mind set, holistic approach and thorough professionalism forms the core of the team named Navin Fluorine. Quality is what we aspire for in every endeavor of ours. Navin Fluorines strict vigil on the environmental norms and safety measures at every step of the manufacturing process has resulted in elevating Navin as an entity to rely upon without inhibition.During FY2016, the Company entered into a Joint Venture (JV) Agreement with Piramal Enterprises Limited (PEL) and accordingly a Company by the name of Convergence Chemicals Private Limited (CCPL) has been formed to leverage the Companys rich legacy in fluorine chemistry and the deep outreach of the JV partner in the healthcare space. PEL holds 51% and the Company owns 49% of the equity share capital of CCPL. During the year 2016, the Company entered into an agreement with Honeywell to work together on the new generation refrigerant gas HFO 1234yf. HFO1234yf is a nextgeneration hydro fluoroolefin (HFO) refrigerant with GWP less than 1 and is a near dropin replacement for R134a, a hydro fluoro carbon (HFC), for use in vehicle air conditioning systems globally. This agreement depicts Honeywells confidence in Companys capabilities in developing new generation fluoro intermediates.At the 19th Annual General Meeting of the Company held on 29 June 2017, Members had passed Resolution approving subdivision of shares in the ratio of 5 Equity Shares of Rs2 each for every 1 Equity Share of Rs10 each. The record date for the aforesaid subdivision was 20 July 2017. Accordingly, the face value of equity shares of the Company stands reduced to Rs2/ per share.During the current year, the Company approved a capital expenditure of Rs11500 lakhs towards creating additional cGMP capacity and associated infrastructure. This capex is underway at the Companys Dewas facility, which is the hub of the CRAMS activities. During the year 2018, Companys business relating to manufacture and sale of Specialty Fluorochemicals at Dahej was transferred to Convergence Chemicals Private Limited, with effect from 1 December 2017, on a going concern basis by way of slump sales together with all the identified assets, liabilities, consents, permissions, services of employees etc.During FY 2019, the Company had entered into a Joint Venture (JV) agreement with Piramal Enterprises Limited (PEL) and accordingly a company by the name of Convergence Chemicals Private Limited (CCPL) has been formed to leverage the Companys capability in niche fluorination chemistry and deep outreach of the JV partner in the healthcare space. PEL holds 51% and the Company owns 49% of the equity share capital of CCPL. During the year 2019, a 100% subsidiary, NFIL (UK) Ltd was formed in the UK to acquire the balance shareholding of 49% from the shareholders of Manchester Organics Ltd. During the year, the Company made further infusion of 830 K into NFIL (UK) Ltd., which has been utilized to service the HDFC Bahrain Term Loan taken by NFIL (UK) Ltd. to part finance the 49% acquisition of MOL.In FY 201920, the Company started operations of cGMP3 at its Dewas site in Madhya Pradesh. It increased its presence in Europe helping create a robust customer pipeline, utilize additional capacities and derisk the Companys dependence on select customers. Besides, it diversified its product portfolio away from 23 compounds to an array of compounds and complex chemistries. The Company embarked on a greenfield expansion in Dahej in 2020 and invested approximately Rs. 500 crores.In FY 202021, Company invested Rs. 19,500 lakhs for setting up of a MultiPurpose Plant (MPP). It invested a capital expenditure of Rs. 9,000 lakhs towards site development and related infrastructure on approx. 74 acres of land for greenfield projects at Dahej in Gujarat. It signed a 410 million multiyear contract with a global company for manufacture and supply of a High Performance Product (HPP) in the fluoro chemicals space. It divested its shareholding in a JVC, Convergence Chemicals Private Limited (CCPL), pursuant to a Joint Venture Agreement between Piramal Enterprises Limited (PEL) and the Company. It commissioned a new plant for a fluorine building block for a number of chemistries done in Contract Research and Manufacturing Services (CRAMS). It established a significant refrigerant gas presence in the life science and crop science industries where it is used as a building block for the manufacture of a number of products. In FY 202122, Companys Surat plant developed technologies for several products, of which 4 products were commercialised. It increased the capacity of one of the inorganic product by 50% through business process reengineering. It addressed diverse customer requirements and enhanced products quality, strengthening customer retention. It further implemented BMR (Batch Manufacturing Records), enhancing data capture directly from the distributed control system. It invested Rs. 75 crores in capital investment to enhance and debottleneck manufacturing capacity of cGMP3 plant. It invested Rs. 78.65 crore for infrastructure development and capability upgradation at Bhestan site. It made equipment modifications that empowered the unit to perform reactions at deep subzero temperatures. It installed specialised software and engaged an international consultant to strengthen its documentation management system. It developed 4 products that were transferred to the main plant for onward commercialisation. It expanded manufacturing footprint and upgraded infrastructure, enhancing capacity by 25%. In 202223, the High Performance Products (HPP) business commenced plant operations at Dahej Unit. The Specialty Chemicals business also commenced operations at Dahej Unit to supply fluorine based agri intermediates.
Read More

Navin Fluorine International Ltd FAQs

Navin Fluorine International Ltd shares are currently priced at 3574.15 on NSE and 3571.95 on BSE as of 12/11/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Navin Fluorine International Ltd [NAVINFLUOR] share was -5.69. The Navin Fluorine International Ltd [NAVINFLUOR] share hit a 1-year low of Rs. 2875.95 and a 1-year high of Rs. 3979.45.

The market cap of Navin Fluorine International Ltd is Rs. 17726.05 Cr. as of 12/11/2024 12:00:00 AM.

The PE ratios of Navin Fluorine International Ltd is 101.65 as of 12/11/2024 12:00:00 AM.

The PB ratios of Navin Fluorine International Ltd is 7.45 as of 12/11/2024 12:00:00 AM

The Mutual Fund Shareholding was 15.2% at the end of 12/11/2024 12:00:00 AM.

You can easily buy Navin Fluorine International Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -